Aldehyde-containing thromboxane B, 1,9-lactone intermediates

ABSTRACT

The present specification provides novel intermediates and novel processes for the synthesis of various side chain and skeletal analogs of Thromboxane B 2  (11β-homo-11a-oxa-PGF 2 α). These analogs are particularly and especially useful as reproductive cycle control agents.

CROSS REFERENCE TO RELATED APPLICATION

The present application is a divisional application of Ser. No. 716,473, filed Aug. 20, 1976, now issued as U.S. Pat. No. 4,070,384; which is a continuation-in-part of Ser. No. 676,894, filed Apr. 14. 1976, issued as U.S. Pat. No. 4,018,804 on Apr. 19, 1977.

The present invention relates to processes and intermediates for Thromboxane B compounds for which the essential material constituting a disclosure therefor is incorporated by reference herein from U.S. Pat. No. 4,020,173, issued Apr. 26, 1977 and U.S. Pat. No. 4,070,384, issued Jan. 24, 1978. One species of the present invention is (8S,9R,12S)-8[(1'S)-3'-oxo-1'-hydroxypropyl]-9,12-dihydroxy-cis-5-trans-10-heptadecadienoic acid, 9,12-diacetate, 1,1'-lactone. 

I claim:
 1. A thromoboxane intermediate of the formula: ##STR1## wherein Z₁ is (1) CIS--CH═CH--CH₂ --(CH₂)_(g) --CH₂ --,(2) cis--CH═CH --CH₂ --(CH₂)_(g) --CF₂ --, (3) cis--CH₂ --CH═CH--(CH₂)_(g) --CH₂ --, (4) --(ch₂)₃ --(ch₂)_(g) --CH₂ --, (5) --(ch₂)₃ --(ch₂)_(g) --CF₂ --, (6) --ch₂ --o--ch₂ --(ch₂)_(g) --CH₂ --, ##STR2## WHEREIN G IS ONE, 2, OR 3; WHEREIN Y₁ is trans--CH═CH-- or --CH₂ --CH₂ --; wherein M₃ is ##STR3## wherein R₅ is hydrogen or methyl and R₃₁ is a hydroxyhydrogen replacing group; Wherein L₁ is ##STR4## or a mixture of ##STR5## wherein R₃ and R₄ are hydrogen, methyl, or fluoro, being the same or different with the proviso that one of R₃ and R₄ is methyl only when the other is hydrogen or methyl; and Wherein R₇ is ##STR6## wherein 1 is zero, one, two, or three, wherein m is one to 5, inclusive, T is alkyl of one to 3 carbon atoms, inclusive, alkoxy of one to 3 carbon atoms, inclusive, chloro, fluoro, or trifluoromethyl, and s is one, two, or 3, the various T's being the same or different, with the proviso that not more than two T's are other than alkyl, with the further proviso that R₇ is ##STR7## only when R₃ and R₄ are hydrogen or methyl, being the same or different; and wherein R₃₃ is alkyl of one to 5 carbon atoms, inclusive.
 2. (8S,9R,12S)-8[(1'S)-3'-oxo-1'-hydroxypropyl]-9,12-dihydroxy-cis-5-trans-10-heptadecadienoic acid, 9,12-diacetate, 1,1'-lactone, a thromboxane intermediate according to claim
 1. 